Eric is a neuroscientist and the Associate Director of Biogen, a pharmaceutical company in Boston that “discovers, develops and delivers worldwide innovative therapies for people living with serious neurological disorders and diseases.” Eric walks us through the process of the testing and valuation of new products before they can be brought to market.
